Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

References

• KhanMAUpdate on spondylarthropathiesAnn Intern Med200213689690712069564
   PubMed Web of Science ®Google Scholar
• BalAUnluEBaharGAydogEEksiogluEYorganciogluRComparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitisClin Rheumatol20072621121516583185
   PubMed Web of Science ®Google Scholar
• BraunJBollowMNeureLUse of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis Rheum1995384995057718003
   PubMed Web of Science ®Google Scholar
• BraunJBaraliakosXBrandtJSieperJTherapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritidesScand J Rheumatol20053417819016134723
   PubMed Web of Science ®Google Scholar
• GarrettSJenkinsonTKennedyLGWhitelockHGaisfordPCalinAA new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Disease Activity IndexJ Rheumatol199421228622917699630
   PubMed Web of Science ®Google Scholar
• JenkinsonTRMalloriePAWhitelockHKennedyLGGarrettSCalinADefining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology IndexJ Rheumatol199421169416987799351
   PubMed Web of Science ®Google Scholar
• CalinAGarrettSWhitelockHA new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional IndexJ Rheumatol199421228122857699629
   PubMed Web of Science ®Google Scholar
• AndersonJJBaronGvan der HeijdeDFelsonDTDougadosMAnkylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitisArthritis Rheum2001441876188611508441
   PubMed Web of Science ®Google Scholar
• van der HeijdeDLieEKvienTKASDAS, a highly discriminatory ASAS endorsed disease activity score in patients with ankylosing spondylitisAnn Rheum Dis2009681811181819060001
   PubMed Web of Science ®Google Scholar
• GormanJDSackKEDavisJCTreatment of ankylosing spondylitis by inhibition of tumor necrosis factor αN Engl J Med20023461349135611986408
   PubMed Web of Science ®Google Scholar
• BrandtJKhariouzovAListingJSix-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitisArthritis Rheum2003481667167512794835
   PubMed Web of Science ®Google Scholar
• DavisJCvan der HeijdeDBraunJRecombinant human tumor necrosis factor receptor (Etanercept) for treating ankylosing spondylitisArthritis Rheum2003483230323614613288
   PubMed Web of Science ®Google Scholar
• CalinADijkmansBACEmeryPOutcomes of a multicentre randomised clinical trial of etnercept to treat ankylosing spondylitisAnn Rheum Dis2004631594160015345498
   PubMed Web of Science ®Google Scholar
• DavisJCvan der HeijdeDBraunJEfficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitisAnn Rheum Dis20086734635217967833
   PubMed Web of Science ®Google Scholar
• van der HeijdeDDa SilvaJCDougadosMEtanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisAnn Rheum Dis2006651572157716968715
   PubMed Web of Science ®Google Scholar
• BraunJMcHughNSinghAWajdulaJSSatoRImprovement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weeklyRheumatology (Oxford)200746999100417389658
   PubMed Web of Science ®Google Scholar
• CantiniFNiccoliLBenucciMSwitching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week studyArthritis Rheum20065581281617013842
   PubMed Web of Science ®Google Scholar
• KeystoneECSchiffMHKremerJMOnce-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trialArthritis Rheum20045035336314872476
   PubMed Web of Science ®Google Scholar
• Van der LindenSValkenburgHACatsAEvaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteriaArthritis Rheum1984273613686231933
   PubMed Web of Science ®Google Scholar
• Heuft-DorenboschLSpoorenbergAvan TubergenAAssessment of enthesitis in ankylosing spondylitisAnn Rheum Dis20036212713212525381
   PubMed Web of Science ®Google Scholar
• CalinAPortaJFriesJFSchurmanDJClinical history as a screening test for ankylosing spondylitisJAMA197723726132614140252
   PubMed Web of Science ®Google Scholar
• LeeSHLeeYAHongSJYangHIEtanercept 25 mg/week is effective enough to maintain remission for ankylosing spondylitis among Korean patientsClin Rheumatol20082717918117874173
   PubMed Web of Science ®Google Scholar
• LeeJNohJWHwangJWExtended dosing of etanercept 25 mg can be effective in patients with ankylosing spondylitis: a retrospective analysisClin Rheumatol2010291149115420683738
   PubMed Web of Science ®Google Scholar
• Navarro-CompánVMoreiraVAriza-ArizaRHernández-CruzBVargas-EbrónCNavarro-SarabiaFLow doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the diseaseClin Rheumatol20113099399621373780
   PubMed Web of Science ®Google Scholar
• SidiropoulosPKritikosHDSiakkaPLow dose of infliximab is inadequate in most patients with spondylarthropathiesClin Exp Rheumatol20052351351616095121
   PubMed Web of Science ®Google Scholar
• MaksymowychWPJhangriGSLambertRGInfliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safetyJ Rheumatol20022995996512022358
   PubMed Web of Science ®Google Scholar
• JoisRNLeederJGibbALow-dose infliximab treatment for ankylosing spondylitis – clinically and cost-effectiveRheumatology (Oxford)2006451566156916705043
   PubMed Web of Science ®Google Scholar
• HeldmannFDybowskiFSaracbasi-ZenderEFendlerCBraunJUpdate on biologic therapy in the management of axial spondyloarthritisCurr Rheumatol Rep20101232533120665135
   PubMedGoogle Scholar